UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C.  20549

 


 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): February 14, 2017

 


 

LIFEPOINT HEALTH, INC.

(Exact Name of Registrant as Specified in Charter)

 

Delaware

 

000-51251

 

20-1538254

(State or Other Jurisdiction
of Incorporation)

 

(Commission File Number)

 

(IRS Employer
Identification No.)

 

330 Seven Springs Way
Brentwood, Tennessee

 

37027

(Address of Principal Executive Offices)

 

(Zip Code)

 

(615) 920-7000

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or address, if changed since last report)

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o             Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o             Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o             Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o             Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On February 14, 2017, Paul D. Gilbert resigned as Executive Vice President and Chief Legal Officer of LifePoint Health, Inc. (the “Company”), effective as of such date, but Mr. Gilbert will remain a non-executive employee of the Company until March 31, 2017, to assist with certain transition matters.

 

In connection with his resignation, Mr. Gilbert entered into a voluntary separation and general release agreement with the Company.  The agreement provides for (i) a release of all claims by Mr. Gilbert in favor of the Company, subject to customary exceptions, (ii) a 24 month non-solicitation covenant by Mr. Gilbert and (iii) payment by the Company to Mr. Gilbert of his base salary for 12 months and a payment equal to six months of COBRA premiums.  In addition, Mr. Gilbert will be eligible to receive an annual bonus based on 2017 performance, up to a maximum of $250,000.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

LIFEPOINT HEALTH, INC .

 

 

 

 

By:

/s/ Michael S. Coggin

 

 

Name: Michael S. Coggin

 

 

Title: Executive Vice President and Chief Financial Officer

 

 

 

Dated: February 16, 2017

 

 

 

3


LifePoint Health, Inc. (NASDAQ:LPNT)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more LifePoint Health, Inc. Charts.
LifePoint Health, Inc. (NASDAQ:LPNT)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more LifePoint Health, Inc. Charts.